Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
NCT01283789
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Lapatinib and RAD-001
Sponsor
University of Kansas Medical Center
Collaborators
[object Object]
[object Object]